Concurrent Hypermethylation of SFRP2 and DKK2 Activates the Wnt/β-Catenin Pathway and Is Associated with Poor Prognosis in Patients with Gastric Cancer |
Wang, Hao
(National Engineering Research Center for Miniaturized Detection Systems, School of Life Sciences, Northwest University)
Duan, Xiang-Long (Second Department of General Surgery, Shaanxi Provincial People's Hospital) Qi, Xiao-Li (National Engineering Research Center for Miniaturized Detection Systems, School of Life Sciences, Northwest University) Meng, Lei (National Engineering Research Center for Miniaturized Detection Systems, School of Life Sciences, Northwest University) Xu, Yi-Song (National Engineering Research Center for Miniaturized Detection Systems, School of Life Sciences, Northwest University) Wu, Tong (National Engineering Research Center for Miniaturized Detection Systems, School of Life Sciences, Northwest University) Dai, Peng-Gao (National Engineering Research Center for Miniaturized Detection Systems, School of Life Sciences, Northwest University) |
1 | Behrens, J., von Kries, J.P., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. (1996). Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382, 638-642. DOI |
2 | Cadigan, K.M., and Nusse, R. (1997). Wnt signaling: a common theme in animal development. Genes Dev. 11, 3286-3305. DOI |
3 | Cheng, Y.Y., Yu, J., Wong, Y.P., Man, E.P., To, K.F., Jin, V.X., Li, J., Tao, Q., Sung, J.J., Chan, F.K., et al. (2007). Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. Br. J. Cancer 97, 895-901. DOI |
4 | Clements, W.M., Wang, J., Sarnaik, A., Kim, O.J., MacDonald, J., Fenoglio-Preiser, C., Groden, J., and Lowy, A.M. (2002). beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res. 62, 3503-3506. |
5 | Ferlay, J., Shin, H.R., Bray, F., Forman, D., Mathers, C., and Parkin, D.M. (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 127, 2893-2917. DOI |
6 | Ford, C.E., Jary, E., Ma, S.S., Nixdorf, S., Heinzelmann-Schwarz, V.A., and Ward, R.L. (2013). The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells. PloS one 8, e54362. DOI |
7 | Giles, R.H., van Es, J.H., and Clevers, H. (2003). Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653, 1-24. |
8 | Gonzalez-Sancho, J.M., Brennan, K.R., Castelo-Soccio, L.A., and Brown, A.M. (2004). Wnt proteins induce dishevelled phosphorylation via an LRP5/6- independent mechanism, irrespective of their ability to stabilize beta-catenin. Mol. Cell. Biol. 24, 4757-4768. DOI |
9 | Hirata, H., Hinoda, Y., Nakajima, K., Kawamoto, K., Kikuno, N., Kawakami, K., Yamamura, S., Ueno, K., Majid, S., Saini, S., et al. (2009). Wnt antagonist gene DKK2 is epigenetically silenced and inhibits renal cancer progression through apoptotic and cell cycle pathways. Clin. Cancer Res. 15, 5678-5687. DOI |
10 | Hosoya, K., Yamashita, S., Ando, T., Nakajima, T., Itoh, F., and Ushijima, T. (2009). Adenomatous polyposis coli 1A is likely to be methylated as a passenger in human gastric carcinogenesis. Cancer Lett. 285, 182-189. DOI |
11 | Kikuchi, A., Yamamoto, H., Sato, A., and Matsumoto, S. (2012). Wnt5a: its signalling, functions and implication in diseases. Acta Physiol. 204, 17-33. DOI |
12 | Li, S., Wang, C., Liu, X., Hua, S., and Liu, X. (2015). The roles of AXIN2 in tumorigenesis and epigenetic regulation. Familial Cancer 14, 325-331. DOI |
13 | Liu, G., Bafico, A., and Aaronson, S.A. (2005). The mechanism of endogenous receptor activation functionally distinguishes prototype canonical and noncanonical Wnts. Mol. Cell. Biol. 25, 3475-3482. DOI |
14 | Lu, W., Yamamoto, V., Ortega, B., and Baltimore, D. (2004a). Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth. Cell 119, 97-108. DOI |
15 | Nojima, M., Suzuki, H., Toyota, M., Watanabe, Y., Maruyama, R., Sasaki, S., Sasaki, Y., Mita, H., Nishikawa, N., Yamaguchi, K., et al. (2007). Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer. Oncogene 26, 4699-4713. DOI |
16 | Lu, X., Borchers, A.G., Jolicoeur, C., Rayburn, H., Baker, J.C., and Tessier-Lavigne, M. (2004b). PTK7/CCK-4 is a novel regulator of planar cell polarity in vertebrates. Nature 430, 93-98. DOI |
17 | Mann, B., Gelos, M., Siedow, A., Hanski, M.L., Gratchev, A., Ilyas, M., Bodmer, W.F., Moyer, M.P., Riecken, E.O., Buhr, H.J., et al. (1999). Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc. Natl. Acad. Sci. USA 96, 1603-1608. DOI |
18 | Niehrs, C. (2006). Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25, 7469-7481. DOI |
19 | Ooi, C.H., Ivanova, T., Wu, J., Lee, M., Tan, I.B., Tao, J., Ward, L., Koo, J.H., Gopalakrishnan, V., Zhu, Y., et al. (2009). Oncogenic pathway combinations predict clinical prognosis in gastric cancer. PLoS Genet. 5, e1000676. DOI |
20 | Oishi, I., Suzuki, H., Onishi, N., Takada, R., Kani, S., Ohkawara, B., Koshida, I., Suzuki, K., Yamada, G., Schwabe, G.C., et al. (2003). The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells 8, 645-654. DOI |
21 | Veeck, J., Noetzel, E., Bektas, N., Jost, E., Hartmann, A., Knuchel, R., and Dahl, E. (2008). Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Mol. Cancer 7, 83. DOI |
22 | Sato, H., Suzuki, H., Toyota, M., Nojima, M., Maruyama, R., Sasaki, S., Takagi, H., Sogabe, Y., Sasaki, Y., Idogawa, M., et al. (2007). Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis 28, 2459-2466. DOI |
23 | Silva, A.L., Dawson, S.N., Arends, M.J., Guttula, K., Hall, N., Cameron, E.A., Huang, T.H., Brenton, J.D., Tavare, S., Bienz, M., et al. (2014). Boosting Wnt activity during colorectal cancer progression through selective hypermethylation of Wnt signaling antagonists. BMC Cancer 14, 891. DOI |
24 | Tsuchiya, T., Tamura, G., Sato, K., Endoh, Y., Sakata, K., Jin, Z., Motoyama, T., Usuba, O., Kimura, W., Nishizuka, S., et al. (2000). Distinct methylation patterns of two APC gene promoters in normal and cancerous gastric epithelia. Oncogene 19, 3642-3646. DOI |
25 | Wang, Z.K., Liu, J., Liu, C., Wang, F.Y., Chen, C.Y., and Zhang, X.H. (2012). Hypermethylation of adenomatous polyposis coli gene promoter is associated with novel Wnt signaling pathway in gastric adenomas. J. Gastroenterol. Hepatol. 27, 1629-1634. DOI |
26 | Yu, J., Tao, Q., Cheng, Y.Y., Lee, K.Y., Ng, S.S., Cheung, K.F., Tian, L., Rha, S.Y., Neumann, U., Rocken, C., et al. (2009). Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer. Cancer 115, 49-60. DOI |
27 | Woo, D.K., Kim, H.S., Lee, H.S., Kang, Y.H., Yang, H.K., and Kim, W.H. (2001). Altered expression and mutation of beta-catenin gene in gastric carcinomas and cell lines. Int. J. Cancer 95, 108-113. DOI |
28 | Yoda, Y., Takeshima, H., Niwa, T., Kim, J.G., Ando, T., Kushima, R., Sugiyama, T., Katai, H., Noshiro, H., and Ushijima, T. (2015). Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer. Gastric Cancer 18, 65-76. DOI |
![]() |